Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1979 2
1980 5
1981 4
1982 5
1983 2
1984 6
1985 3
1986 7
1987 4
1988 1
1989 9
1990 3
1991 5
1992 5
1993 9
1994 4
1995 3
1996 5
1997 4
1998 8
1999 2
2000 4
2001 3
2002 3
2003 3
2004 4
2005 5
2006 7
2007 10
2008 4
2009 2
2010 4
2011 6
2012 3
2013 4
2014 1
2015 6
2016 1
2017 1
2018 7
2019 2
2020 3
2021 10
2022 11
2023 9
2024 11
2025 13
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Results by year

Filters applied: . Clear all
Page 1
[Vomiting].
Camici M. Camici M. Minerva Med. 2002 Aug;93(4):295-302. Minerva Med. 2002. PMID: 12207199 Review. Italian.
Radiotherapy in the era of COVID-19.
Lancia A, Bonzano E, Bottero M, Camici M, Catellani F, Ingrosso G. Lancia A, et al. Among authors: camici m. Expert Rev Anticancer Ther. 2020 Aug;20(8):625-627. doi: 10.1080/14737140.2020.1785290. Epub 2020 Jul 7. Expert Rev Anticancer Ther. 2020. PMID: 32552073 No abstract available.
[Thrombin].
Camici M, Sagripanti A, Di Mitri R. Camici M, et al. Minerva Med. 2000 May-Jun;91(5-6):105-12. Minerva Med. 2000. PMID: 11084844 Review. Italian.
Purine-Metabolising Enzymes and Apoptosis in Cancer.
Camici M, Garcia-Gil M, Pesi R, Allegrini S, Tozzi MG. Camici M, et al. Cancers (Basel). 2019 Sep 12;11(9):1354. doi: 10.3390/cancers11091354. Cancers (Basel). 2019. PMID: 31547393 Free PMC article. Review.
The Inside Story of Adenosine.
Camici M, Garcia-Gil M, Tozzi MG. Camici M, et al. Int J Mol Sci. 2018 Mar 9;19(3):784. doi: 10.3390/ijms19030784. Int J Mol Sci. 2018. PMID: 29522447 Free PMC article. Review.
Vitamin D and heart.
Camici M, Galetta F, Franzoni F, Carpi A, Zangeneh F. Camici M, et al. Intern Emerg Med. 2013 Apr;8 Suppl 1:S5-9. doi: 10.1007/s11739-013-0926-x. Intern Emerg Med. 2013. PMID: 23462894 Review.
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data.
Piselli P, Tavelli A, Cimaglia C, Muccini C, Bandera A, Marchetti GC, Torti C, Mazzotta V, Pipitò L, Caioli A, Girardi E, Antinori A, Serraino D, d'Arminio Monforte A, Cingolani A; Icona Foundation Study Group. Piselli P, et al. Int J Cancer. 2025 Sep 15;157(6):1142-1153. doi: 10.1002/ijc.35493. Epub 2025 May 29. Int J Cancer. 2025. PMID: 40437996 Free PMC article.
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians' and nurses' points of view.
Cingolani A, Tavelli A, De Benedittis S, Mastrorosa I, Muccini C, Bini T, Carraro A, Compagno M, Mazzitelli M, Guastavigna M, Cernuschi M, Torti C, Antinori A, d'Arminio Monforte A; ICONA Foundation Study group. Cingolani A, et al. J Antimicrob Chemother. 2024 Oct 1;79(10):2662-2667. doi: 10.1093/jac/dkae273. J Antimicrob Chemother. 2024. PMID: 39140512 Free PMC article.
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation.
Mussini C, Giacomelli A, Quiros-Roldan E, Mazzotta V, Di Biagio A, De Vito A, Costantini A, D'Ettorre G, Giacometti A, Vergori A, Tavelli A, Malagnino V, Castagna A, Chester J, Antinori A, d'Arminio Monforte A, Cozzi-Lepri A; Icona Foundation Cohort Study for the Icona Foundation Study Group. Mussini C, et al. EClinicalMedicine. 2025 Jul 24;86:103368. doi: 10.1016/j.eclinm.2025.103368. eCollection 2025 Aug. EClinicalMedicine. 2025. PMID: 40740293 Free PMC article.
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort.
Gagliardini R, De Benedittis S, Tavelli A, Lapadula G, Mazzotta V, Bruzzesi E, Cervo A, Carrozzo G, Saracino A, Rusconi S, Marchetti G, Ceccherini-Silberstein F, Antinori A, d'Arminio Monforte A, Muccini C; Icona Foundation Study Group. Gagliardini R, et al. J Antimicrob Chemother. 2025 Aug 1;80(8):2169-2178. doi: 10.1093/jac/dkaf184. J Antimicrob Chemother. 2025. PMID: 40570134 Free PMC article.
224 results